Top 5 Stocks to Watch for Long-Term Gains: Brokerage Picks for 2026
As Indian markets continue to evolve, top brokerage firms are identifying high-growth opportunities across diverse sectors like logistics, fintech, and industrials. Based on attractive valuations and strong structural tailwinds, several stocks are positioned to deliver significant long-term returns for patient investors.
Logistics and Industrial Growth: Delhivery and Kirloskar Oil
In the logistics sector, Motilal Oswal has maintained a bullish stance on Delhivery. With the company currently trading at ₹461, the brokerage has set a target price of ₹580, implying a potential upside of approximately 26%. This recommendation underscores the growing demand for organized supply chain solutions in India.
Similarly, the industrial segment shows promise through Kirloskar Oil Engines. Motilal Oswal has reiterated its 'Buy' rating for the company, assigning a target price of ₹2,350. Given its Last Traded Price (LTP) of ₹1,992, investors could see a potential upside of roughly 18%, driven by the broader industrial recovery and capital expenditure cycles.
Fintech and Insurance: High Upside in Pine Labs and Niva Bupa
The fintech space is highlighted by a massive potential gain in Pine Labs. Emkay has maintained a 'Buy' rating on the company with a target price of ₹225. With the stock currently trading at ₹152, the brokerage sees an impressive potential upside of about 48%, marking it as one of the most aggressive growth picks in this list.
In the insurance sector, Motilal Oswal remains optimistic about Niva Bupa Health Insurance. The brokerage has retained its 'Buy' rating with a target price of ₹100. Based on the current market price of ₹87, the company anticipates a potential upside of nearly 15%, reflecting the increasing penetration of health insurance in the Indian market.
Manufacturing Excellence: Timken India
Rounding out the list of high-potential stocks is Timken India, representing the manufacturing and precision engineering sector. Geojit Investments has assigned a 'Buy' rating to the stock, setting a target price of ₹4,207. At its current market price of ₹3,694, the brokerage expects a steady upside of approximately 13%.
These recommendations highlight a strategic spread across the economy, offering investors a way to participate in India's consumption, digital infrastructure, and manufacturing stories. While the potential for double-digit returns is significant, investors should always consider their own risk appetite and the long-term fundamentals of these companies.
Key Takeaways
- Maximum Upside Potential: Pine Labs emerges as the standout pick with a projected upside of 48%, according to Emkay.
- Diverse Sectoral Exposure: The recommended stocks cover a wide range of sectors, including logistics (Delhivery), fintech (Pine Labs), health insurance (Niva Bupa), and industrials (Kirloskar Oil and Timken India).
- Consistent Brokerage Optimism: Major firms like Motilal Oswal, Emkay, and Geojit are focusing on companies with strong valuation support for long-term growth.